The effect of DC+CIK combined therapy on rat liver cancer model and its modulatory effect on immune functions.

Abstract

DC+CIK combined therapy can protect the host against tumors invasion via modulating body immune or liver function, regulating apoptosis/anti-apoptosis balance, which shows better efficacy than CIK alone, and can work as a novel biological therapeutic strategy for liver cancer.